The role of adipokines in the pathogenesis of rheumatic diseases
Search results for: weight
A&R Abstracts – ADIPOKINES
For Further Reading
Translational Rheumatology
Changes to the NIH CTSA program may bring more support to bench-to-bedside research
How Energy Shifts Lead to Systemic Illness
The impact of adaptive energy programs on the manifestations of chronic inflammatory disease
Pain Perspective in Scleroderma
Systemic sclerosis (SSc; scleroderma) is a disease in which inflammatory and fibrotic changes result in overproduction and accumulation of collagen and other extracellular matrix proteins, resulting in intimal vascular damage, fibrosis, and occasionally organ dysfunction affecting the gastrointestinal, lung, heart, and renal systems. There are two classifications of SSc—limited cutaneous or CREST (calcinosis, Raynaud’s, esophageal dysmotility, sclerodactyly, and telangectasias) syndrome, where skin thickening occurs mainly in the distal extremities and facial/neck areas and internal organ involvement, if present, occurs later in the disease process; and diffuse cutaneous disease where there is a more rapid progression of skin thickening from distal to proximal and organ involvement can be severe and occur early in the disease. As noted by various authors, there is no “crystal ball” into which one can look to see the outcome of the disease, and involvement varies significantly from one person to the next.
Revising Fibromyalgia: One Year Later
The 2010 ACR fibromyalgia criteria capture the broader clinical picture and help ensure more appropriate diagnosis and management by primary care
Rheum with a View
Panush’s perspectives on selections from the literature
Learn a New Language
Rheumatology trainees will need to know basic and clinical science to be successful at translation
Coding Corner Question
June’s Coding Challenge
The Saddest Disease to Prevent
When preventing a disease is harder than its treatment
- « Previous Page
- 1
- …
- 75
- 76
- 77
- 78
- 79
- …
- 88
- Next Page »